American Regent

INJECTAFER

Manufacturer:

American Regent

Injectafer HCPCS:

J1439

HCPCS Code Descriptor:

Injection, ferric carboxymaltose, 1 mg

Category:

J Code

Injectafer NDCs:

00517-0650-01, 00517-0602-01

Primary Type:

Anti-Anemia

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Injectafer:

INJECTAFER is an Anti-Anemia drug manufactured by American Regent and administered via the Intravenous route of administration. The J Code: J1439 is aligned to the drug INJECTAFER.

Injectafer is an intravenous form of iron replacement. Injectafer can be used to treat iron deficiency anemia, also known as IDA, for patients who have not responded well to oral forms of iron supplements. It can also be used to treat IDA in patients with non-dialysis dependent chronic kidney disease. With IV iron treatments such as injectafer, 100% of the iron they contain is delivered into the bloodstream, which may help patients who have had unsatisfactory responses to other iron replacement treatments.

ACCESS PRICING AND MORE BY REGISTERING

J1439 Added Date:

January 1, 2015

J1439 Effective Date:

January 1, 2015

J1439 Termination Date:

HCPCS Active

Injectafer billing and coding information can be found through American Regent at the link below:
Injectafer patient assistance information can be found through American Regent’s VenAccess Program at the URL: http://venofer.com/venaccess
INJECTAFER prescribing information can be found at the link below:
Information regarding INJECTAFER’s side effects can be found at MedlinePlus